Anticardiolipin antibodies and β2-glycoprotein I
- 1 April 1996
- journal article
- Published by SAGE Publications in Lupus
- Vol. 5 (2) , 156-157
- https://doi.org/10.1177/096120339600500213
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Antigenic specificity of the "anticardiolipin" antibodies [letter; comment]Blood, 1995
- Molecular Studies on Phospholipid-Binding Sites and Cryptic Epitopes Appearing on β2-Glycoprotein I Structure Recognized by Anticardiolipin AntibodiesLupus, 1995
- Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies [see comments]Blood, 1994
- Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.The Journal of Experimental Medicine, 1994
- Molecular definition of human β2-glycoprotein (α2-GPI) by cDNA cloning and inter-species differences of β2-GPI in alternation of anticardiolipin bindingInternational Immunology, 1991
- What is the "true" antigen for anticardiolipin antibodies?The Lancet, 1991
- Immunology and Clinical Importance of Antiphospholipid AntibodiesPublished by Elsevier ,1991
- Anticardiolipin cofactor(s) and differential diagnosis of autoimmune diseaseThe Lancet, 1990
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990